CLIA waiver has been granted by the U.S. Food and Drug Administration (FDA) to Syphilis Health Check, which is the first ever waiver for a rapid screening test for syphilis available in the United States. The CLIA waiver has been granted to ... Morningstar.com, 6 days ago
FDA grants CLIA waiver expanding the availability of rapid screening test for syphilis - Medical News Today, 2 days ago
Trinity Biotech PLC Trinity Biotech Announces CLIA waiver - ADVFN Australia, 6 days ago
More from: Stock Nod, MoneyAM...and 37 other sources
The US-headquartered Vanta Bioscience offers toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries. "The acquisition is in line with our business strategy of being an integrated drug discovery services ...Money Today, 1 month ago GVK BIO signs definitive agreement to acquire Vanta Bioscience India Infoline, 1 month ago GVK Biosciences to buy Chennai based Vanta Bio for $5mn Economic Times, 1 month ago GVK Bio acquires US-headquartered Vanta Bioscience Business Standard, 1 month ago
After supporting the dairy and food and beverage industries for more than 30 years, an aseptic fluid handling system has found new applications in the growing biotechnology industry. Researchers in the industry have been perplexed by questions on ...Scientist Live, 5 days ago
"New biotech traits are key to helping us grow more food sustainably to feed the world's growing population," says Bill Raben, soybean farmer from Ridgway, Ill., and ISA chairman. Unfortunately, Raben notes the world lacks a science-based ...Farm Week Now, 6 days ago
Early results for treatment of inflammatory diseases promising for Tacoma-born biotech research company [The News Tribune (Tacoma, Wash.)]
Dec. 22--It looks like water, it feels like water and it could change the way medical science attacks disease. Quietly, slowly, a revolution continues to simmer on the east side of the Thea Foss Waterway at a Tacoma-born biotechnology research firm ...BusinessWeek, 24 minutes ago
For biotech investors, the news that AbbVie has cut a deal with Express Scripts to sell its new hepatitis C treatment, the Viekira Pak, at a significant and undisclosed discount to its $83,319 seems nothing short of disaster. It means that Gilead ...Forbes.com, 3 hours ago
Syngenta announced today that it has received approval for the Agrisure Viptera® trait (event MIR162) from China's regulatory authorities, formally granting import approval. The approval covers corn grain and processing byproducts, such as dried ...Domestic Fuel, 6 hours ago UPDATE 1-Syngenta says China approves imports of contentious biotech corn CNBC, 8 hours ago Syngenta says China approves imports of contentious biotech corn Sharenet, 8 hours ago UPDATE 2-China approves imports of GMO Syngenta corn, Pioneer soy CNBC, 3 hours ago
By Adam Feuerstein | 12/22/14 - 06:14 AM EST BOSTON ( TheStreet ) -- The exclusive hepatitis C pharmacy deal struck between Express Scripts ( ESRX ) and AbbVie ( ABBV ) is a serious, perhaps permanent, blow to the multi-year biotech stock ...TheStreet.com, 9 hours ago Express Scripts (ESRX) Sides With AbbVie (ABBV), Abandons Gilead Sciences (GILD) Bidness Etc, 8 hours ago
Summary AbbVie has received approval of its widely-anticipated hepatitis C combination, called Viekira Pak. This regimen has a high cure rate but certain issues when given with a number of other drugs, and has less convenient dosing than Gilead's ...Seeking Alpha, 1 hour ago Gilead Sciences, Inc. Gets Some Competition (but Not Really) Motley Fool, 21 hours ago
Creative Edge Nutrition, Inc. (FITX: OTC Pink Current) | An Interview With Internal Public Relations at CEN Biotech Inc.
- Creative Edge Nutrition, Inc. ( OTC PINK : FITX ) ( PINKSHEETS : FITX ) is pleased to release an interview with our Internal Public Relations addressing shareholder questions. "Today I had the exclusive opportunity to speak to CEN Biotech ...Pink Sheets, 1 day ago CREATIVE EDGE NUTRITION : An Interview With Internal Public Relations at CEN Biotech Inc. 4 Traders, 1 day ago Two Massachusetts biotechs soar in market rally Boston Globe, 3 days ago An Interview With Internal Public Relations at CEN Biotech Inc. AndhraNews.net, 14 hours ago
on your WebpageAdd Widget >Get your members hooked!